AJP - Endo Add DOIs to your references at manuscript stage!
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Am J Physiol Endocrinol Metab 281: E676-E682, 2001;
0193-1849/01 $5.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (19)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sneddon, A. A.
Right arrow Articles by Maltin, C. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sneddon, A. A.
Right arrow Articles by Maltin, C. A.
Vol. 281, Issue 4, E676-E682, October 2001

Elevated IGF-II mRNA and phosphorylation of 4E-BP1 and p70S6k in muscle showing clenbuterol-induced anabolism

A. A. Sneddon, M. I. Delday, J. Steven, and C. A. Maltin

The Rowett Research Institute, Bucksburn, Aberdeen AB21 9SB, Scotland, United Kingdom

Muscle wasting affects large numbers of people, but few therapeutic approaches exist to treat and/or reverse this condition. The beta 2-adrenoceptor agonist clenbuterol produces a muscle-specific protein anabolism in both normal and catabolic muscle and has been used to limit muscle wasting in humans. Because clenbuterol appears to interact with or mimic innervation, its effect on the expression of the neurotrophic agents insulin-like growth factor (IGF)-II and H19 and their putative pathways was examined in normal rat plantaris muscle. The results showed that the well-documented early effects of clenbuterol on protein metabolism were preceded by elevated levels of IGF-II and H19 transcripts together with increased phosphorylation of eukaryotic initiation factor (eIF)4E binding protein-1 (4E-BP1) and p70S6k. By 3 days, transcript levels for IGF-II and H19 and 4E-BP1 and p70S6k phosphorylation had returned to control values. These novel findings indicate that clenbuterol-induced muscle anabolism is potentially mediated, at least in part, by an IGF-II-induced activation of 4E-BP1 and p70S6k.

hypertrophy; beta -agonist; growth factor; protein translation; insulin-like growth factor II; eukaryotic initiation factor 4E binding protein-1


This article has been cited by other articles:


Home page
 PhysiologyHome page
M. Sandri
Signaling in Muscle Atrophy and Hypertrophy
Physiology, June 1, 2008; 23(3): 160 - 170.
[Abstract] [Full Text] [PDF]

Home page
 Physiol. Rev.Home page
G. S. Lynch and J. G. Ryall
Role of {beta}-Adrenoceptor Signaling in Skeletal Muscle: Implications for Muscle Wasting and Disease
Physiol Rev, April 1, 2008; 88(2): 729 - 767.
[Abstract] [Full Text] [PDF]

Home page
 J. Appl. Physiol.Home page
J. J. McCarthy and K. A. Esser
Counterpoint: Satellite cell addition is not obligatory for skeletal muscle hypertrophy
J Appl Physiol, September 1, 2007; 103(3): 1100 - 1102.
[Full Text] [PDF]

Home page
 J. Appl. Physiol.Home page
W. O. Kline, F. J. Panaro, H. Yang, and S. C. Bodine
Rapamycin inhibits the growth and muscle-sparing effects of clenbuterol
J Appl Physiol, February 1, 2007; 102(2): 740 - 747.
[Abstract] [Full Text] [PDF]

Home page
 Exp PhysiolHome page
M. A. Pellegrino, G. D'Antona, S. Bortolotto, F. Boschi, O. Pastoris, R. Bottinelli, B. Polla, and C. Reggiani
Clenbuterol antagonizes glucocorticoid-induced atrophy and fibre type transformation in mice
Exp Physiol, January 1, 2004; 89(1): 89 - 100.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online